Investigation Report on China Sevoflurane Market, 2010-2019

Sevoflurane is an inhalational anaesthetic for maintenance of general anesthesia with the fastest onset and offset.
Reference: 1508301
Price: $2,000.00
Tax included

General

Publisher:
CRI
Geography Covered
China
Publication Date
8/18/2015
Pages
30
Version:
2010
Charts:
30
Language
  • English
  • Chinese
Format
License

Description

Sevoflurane is an inhalational anaesthetic for maintenance of general anesthesia with the fastest onset and offset. And it not only has little influence on circulation, liver and kidney functions but also protects cardiac muscles. Therefore, sevoflurane has become the main inhaled anaesthetic which is especially fit for patients with myocardial damage. Anaesthetic is divided into local and general anaesthetic with the latter dominating the market.
In 1996, Ultane of Abbott entered China, followed by Sevorane of Maruishi and Sevoflurane of Baxter Healthcare Corporation. In 2007 and 2008 respectively, inhaled solution of sevoflurane made by Shanghai Hengrui Pharmaceutical and Lunan Better Pharmaceutical were approved by CFDA to enter the market too.
According to the Chinese government's statistics, the number of hospitalized cases rose from 115 million in 2008 to 192 million in 2013, among which a quarter need operations. And CAGR during this period exceeded 8%. Therefore it is clear to see that as operations rise in number, the demand for anaesthetics will rise too.
According to CRI's market survey, the sales value of sevoflurane in sample hospitals rose from less than CNY 4 million in 2005 to over CNY 400 million in 2014 with CAGR during this period reaching 71%.
According to CRI's market survey, MARUISHI PHARMACEUTICAL CO.,LTD.(JA), Shanghai Hengrui Pharmaceutical Co., Ltd, BAXTER HEALTHCARE CORPORATION(US), Jiangsu Hengrui Medicine Co., Ltd and MARUKO(JA) occupy the market, among which MARUISHI PHARMACEUTICAL CO.,LTD.(JA) had the largest market share of about 41% for sales value in 2014.
As the demand for anaesthetic keeps rising as a result of increasing operations, sevoflurane enjoys good market prospects.

Readers can get at least the following information through this report:
-market size of sevoflurane in China
-competitive landscape of sevoflurane market in China
-price of sevoflurane made by different enterprises in China
-market outlook of sevoflurane in China

The author suggests the following groups of people purchase this report:
- drug makers
-investors/research institutions interested in Chinese medicine market
--any interest in Chinese medicine market, please contact CRI for customized survey service

Table of Contents

1 Related Concepts of Sevoflurane
1.1 Indication
1.2 Sales Status in Global Market

2 Market Profile of Sevoflurane in China
2.1 Patent and Approval Information of Sevoflurane in China
2.2 Major Manufacturers
2.3 Market Size

3 Survey on Sevoflurane Sales in China, 2010-2014
3.1 Sales Value
3.1.1 Overall Sales Value
3.1.2 Sales Value by Regions
3.2 Sales Volume
3.2.1 Overall Sales Volume
3.2.2 Sales Volume by Regions

4 Survey on Market Share of Major Sevoflurane Manufacturers in China, 2010-2014
4.1 Market Share by Sales Value
4.2 Market Share by Sales Volume

5 Survey on Dosage Forms of Sevoflurane in China, 2010-2014
5.1 Share of Different Dosage Forms by Sales Value
5.2 Share of Different Dosage Forms by Sales Volume

6 Reference Price of Sevoflurane in Chinese Hospitals in 2014
6.1 Shanghai Hengrui Pharmaceutical Co., Ltd
6.2 MARUISHI PHARMACEUTICAL CO.,LTD.(Japan)
6.3 Jiangsu Hengrui Medicine Co., Ltd
6.4 BAXTER HEALTHCARE CORPORATION(US)
6.5 Lunan Better Pharmaceutical Co., Ltd

7 Major Manufacturers of Sevoflurane in Chinese Market, 2010-2014
7.1 Shanghai Hengrui Pharmaceutical Co., Ltd
7.2 MARUISHI PHARMACEUTICAL CO.,LTD.(Japan)
7.3 Jiangsu Hengrui Medicine Co., Ltd
7.4BAXTER HEALTHCARE CORPORATION(US)
7.5 Lunan Better Pharmaceutical Co., Ltd

8 Market Outlook of Sevoflurane in China, 2015-2019
8.1 Forecast of Market Size
8.2 Forecast of Competitive Landscape

Table of Selected Charts

Chart Approval Information of Sevoflurane in China
Chart Sevoflurane Sales in China
Chart Sales Value of Sevoflurane in China, 2010-2014
Chart Sales Value of Sevoflurane in Ssome Regions in China, 2010-2014
Chart Sales Volume of Sevoflurane in China, 2010-2014
Chart Sales Volume of Sevoflurane in Some Regions in China, 2010-2014
Chart Market Share of TOP5 Sevoflurane Manufacturers for Sales Value in China, 2010-2014
Chart Sales Value and Market Share of Sevoflurane Made by MARUISHI(Japan) in China, 2010-2014
Chart Sales Value and Market Share of Sevoflurane Made by Shanghai Hengrui in China, 2010-2014
Chart Sales Value and Market Share of Sevoflurane Made by BAXTER(US) in China, 2010-2014
Chart Sales Value and Market Share of Sevoflurane Made by Other Enterprises in China, 2010-2014
Chart Market Share of TOP5 Sevoflurane Manufacturers for Sales Volume in China, 2010-2014
Chart Price of Sevoflurane Made by Shanghai Hengrui in Some Chinese Cities in 2014
Chart Price of Sevoflurane Made by MARUISHI PHARMACEUTICAL CO.,LTD.(JA) in Some Chinese Cities in 2014
Chart Price of Sevoflurane Made by Jiangsu Hengrui Medicine Co., Ltd in Some Chinese Cities in 2014
Chart Price of Sevoflurane Made by BAXTER HEALTHCARE CORPORATION(US) in Some Chinese Cities in 2014
Chart Price of Sevoflurane Made by Lunan Better Pharmaceutical Co., Ltd in Some Chinese Cities in 2014

Related Reports

Scroll